The changes in plasma and dialysate amino acids (AA) in 7 continuous ambulatory peritoneal dialysis (CAPD) children after dialysis with a 1% AA solution were compared with a glucose-containing solution. During the AAexchange, the plasma levels of individual AA reached their peaks after 1 h, with their percentage increments significantly correlated (p < 0.001) with the ratio of the amount of AA in the bag to the basal plasma concentration. The plasma concentration of methionine, valine, phenylalanine, and isoleucine remained higher than the basal value at 4 h. The amount of AA absorbed was 66% after 1 h, and 86% after 4 h and 6 h, corresponding to 2574 &plusmn; 253 &mu;mollkg body wt. During glucose-dialysis (1.36%), levels of histidine, methionine, valine, phenilalanine, and isoleucine were significantly decreased in plasma after 1 h, and stayed low throughout the dialysis period. The loss of AA with the peritoneal effluent was 116 &plusmn; 69 &mu;mol/kg/body wt.
I n the last 10 years, continuous ambulatory peritoneal dialysis (CAPD) has become increasingly pop ular as the therapy of choice for treatment of children with chronic renal failure (CRF) (1) . It is well known that children with CRF grow poorly and some have signs of protein calorie malnutrition. Although a more l iberal diet can be prescribed with the introduction of CAPD, this has failed to normalize growth and to reverse malnutrition (2, 3).
Correspondence to: F. Perfumo, G. Gaslini Institute, Ne phrology Department, Via 5 Maggio, 39,16148 Genoa, Italy. Received May 9, 1989 ; accepted October 13, 1989. Dextrose has been used as the usual osmotic agent. It has been calculated that approximately 77% of the dextrose is absorbed during the dialysis exchange ( 4, 5) . The absorbed dextrose provides up to 21% of the calorie intake for the children (6) . However, its longterm use can lead to clinical and metabolic side effects (7, 8) . In addition, there is an obligatory loss of amino acids (AA) and proteins in effluent dialysis fluid, which can contribute to the protein calorie malnutrition (9, 10) . The losses of individual AA are in proportion to their plasma concentrations and CAPD neither improves nor worsens the abnormal plasma AA profile of uremia (11) .
Initial studies showed that a 1% AA solution is an effective osmotic agent and produces an ultrafiltration similar to that of 1.36% glucose solution (12, 13) .
Thus, an AA solution, in addition to removing excessive fluid and waste, might be able to provide nitrogen to replace protein losses and compensate for inadequate protein uptake. No studies to date have shown improvement in nutritional status, nitrogen balance, or protein synthesis.
This paper compares the changes in plasma and dialysate AA in 7 -CAPD children after dialysis with a 1% AA solution with those after a control exchange with a glucose-containing solution.
PATIENTS
Seven patients, 6 boys and 1 girl, participated in 2 single studies each: 1 with glucose solution, and 1 with AA solution. Clinical data for the patients are presented in Table 1 . Clinically, all the patients were stable on CAPD and had had no peritonitis for at least 2 mon before the study. N o one was grossly malnourished, or had any disorders known to affect AA metabolism other than uremia. The parents had been informed of the nature and purposes of the study and had given their verbal consent.
METHODS
The patients were admitted to the hospital at 8 pm on the night before the investigation and fasted until the end of the study. The overnight exchange was performed with 1.36% glucose solution. Overnight dialysis effluent was drained and the next change, infused over 15 min, was either 1.36% glucose solution or 1% solution of crystalline AA without glucose ( Table 2 ). The AA solution was provided by BaxterTravenol R&D, Europe. Blood samples were taken at 0, 60, 120, 180, 240 min and dialysate also at 360 min. The first 10 mL of dialysate for each sample were discarded. At the end of the study, the fluid was drained and the exact volume recorded. During the 6 h dwelling time, the patients continued to fast. Hepa rinized blood samples drawn for AA analysis were immediately placed on ice until centrifugation at 4 oC.
Plasma was deproteinized with sulphosalicylic acid (SSA, 60% w/v), 50 &mu;L per 1 mL of plasma. After centrifugation, the supernatant was filtered through 0.45 &mu;m HA type Millipore filters and stored at -80°C until analyzed. This SSA extract was subsequently analyzed for AA by HPLC after pre-column derivati zation with orthophthaldialdehyde (OPA), with fluorescence detection of OPA-2mercaptoethanol derivatives of AA (14) . Dialysate samples were deproteinized (SSA, 4% w/v) 166 &mu;l per 1 mL of dialysate, filtered, and analyzed as above. Data are presented as means &plusmn; SD. The significance of differences was determined by the t-test for paired data and a p < 0.05 was considered statistically significant.
RESULTS
During the exchange with glucose dialysate, some plasma AA levels had declined by the first hour, and by the fourth hour had not returned to the basal values (Table 3) . During glucose dialysis, there was a progressive increase in dialysate AA concentration. AA loss in the dialysate was 116 &plusmn; 69 &mu;mollkg body weight. At 4 h, the DIP ranged from 0.41 to 0.78 with a
During the AA exchange, several different responses in plasma AA were observed (Table 4 ). The plasma AA showing the greatest responses were those present in the original AA dialysate solution. Peak levels of total-AA (TAA), essential-AA (EAA), branchedchain-AA (BCAA), and nonessential-AA (NEAA) were reached at 1 hour (Figure 1 ). Different increases were discerned for different AA, with the highest percentage increases in those with the highest ratio between the concentration in the solution and the basal plasma concentration. For these AA, there was a linear correlation between this ratio and the percentage increase in plasma concentration of the AA (Figure 2 ). Of the AA not contained in the original solution, asparagine was decreased. At 4 h methionine, valine, phenylalanine, and isoleucine remained higher than the basal values.
During AA dialysis, absorption of 87 &plusmn; 3% was complete by 4 h and remained the same at 6 h. At 1 h, 66 &plusmn; 10% of the AA absorption was completed.
It is interesting to observe (Figure 3 ) that during AA dialysis, there was also a significantly different loss of the AA not contained in the original dialysate, as compared with glucose dialysis (30.8 &plusmn; 24.9 &mu;moll kg vs 44.3 &plusmn; 30.1; p < 0.01). Fluid removal was not significantly different with both osmotic agents (95.9 &plusmn; 27.4% of infused volume for AA exchange and 119.7 &plusmn; 26.6% for dextrose solution). No side effects were observed.
DISCUSSION
The use of an AA-containing dialysis solution (1% ) offers some advantages over the standard glucose solution. Its use in one exchange daily can reduce the daily absorption of glucose, which seems to be associated with hypertriglyceridemia (7) . Another advantage is the possibility of compensating for the obliga tory loss of AA in the dialysis effluent ( 15) , which may be one of the factors involved in the genesis of protein calorie malnutrition seen in some patients on CAPD. Furthermore, the use of an AAcontaining solution can compensate for the low protein intakes of some patients.
The aim of this study was to compare the behaviour of plasma concentration, absorption, and losses of AA, during and after dialysis, with the 2 different types of solutions. The consequences of and mechanisms involved in AA metabolism with these 2 types of solutions have been already reported (16, 17) . In this study, the authors mainly considered the transfer of different AA, with special attention to the modifications of single AA levels, induced by the use of an AA solution in order to detect the risk of an excessive and nonphysiological increases in plasma concentrations.
Plasma l evels of some AA, BCAA, methionine, and phenylalanine, increased and remained high at the end of the study. BCAA persisted high, perhaps because of defective uptake by peripheral tissue especially muscle (18, 19) . The other AA first increased rapidly esp ecially arginine (by 97.6% ) and then declined to basal values, indicating complete metabolism.
This pattern of plasma AA during AA dialysis resembles that observed after a protein meal (20, 21) , with the exception of a larger increment of methionine and phenylalanine, probably due to the high content in the dialysis fluid.
The AA losses with CAPD have been evaluated as about 10,000 &mu;mol/day ( ~1.1 g) (10) . Using glucose solution in a single exchange, the authors found a mean loss of 116 j: 69 &mu;mol/kg of AA. That was comparable with the mean loss of 280.2 j: 24.7 &mu;mol/kg from the three glucose based dialysis exchanges reported by others (22, 23, 24) . During dialysis with the AA-containing solution, the total absorption was 2574 j: 253&mu;mol/kg/exchange, similar to the values of a net absorption of 2500 j: 400 &mu;mol AA/kg/exchange reported in children receiving CAPD with a single cycle with AA dialysis solution (22, 23, 24) . This amount corresponds to ~0.28 g of nitrogen/kg/exchange. The availability of this extra amount of free AA might improve nitrogen balance and protein synthesis.
An additional important finding is that the losses of AA not contained in the original dialysis solution were lower during AAdialysis. Others evaluating D/P ratios reported an increased loss of 6 AA (taurine, aspartic acid, asparagine, glutamic acid, citruline, and ornithine) not contained in the dialysis solution (25). This discrepancy could be partly attributed to the fact that this study additionally measured glutamine, which accounts for 50-60% of the total loss of these AA.
In conclusion, the use of an AA dialysis solution, with 1 exchange per day, could limit the daily glucose load and compensate for AA losses by supplying an extra amount of AA and by reducing the loss of AA not contained in the solution. The pattern of AA in plasma following AA-dialysis resembles that observed after a protein meal and there is no evidence of persistently high nonphysiologicallevels.
